New hope for Tough-to-Treat blood cancer: phase 3 trial launches
NCT ID NCT06158841
First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 10 times
Summary
This study tests a new drug called etentamig against standard treatments for adults with multiple myeloma that has returned or stopped responding. About 380 participants will receive either etentamig or a standard therapy chosen by their doctor. The goal is to see if etentamig can delay cancer growth and improve response rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
421 people
The number who actually took part.
- Started
-
May 2024
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Eastern Cooperative Oncology Group (ECOG) performance of \<= 2. * Diagnosis of relapsed/refractory (R/R) multiple myeloma (MM) during or after the participant's last treatment as stated in the protocol. * Must have measurable disease with at least 1 of the following assessed within 28 days of enrollment: * Serum M-protein \>= 0.5 g/dL (\>= 5 g/L). * Urine M-protein \>= 200 mg/24 hours. * In participants without measurable serum or urine M protein, serum free light chain (FLC) \>= 100 mg/L (10 mg/dL) (involved light chain)and an abnormal serum kappa lambda ratio. * Must have received at least 2 or more lines of therapy, including a proteasome inhibitor (PI), an immunomodulatory imide (IMiD), and an anti-CD38 monoclonal antibody (mAb). \-- US and Puerto Rico only: Participant must have received at least 1 or more line of therapy, including exposure to a PI, an IMiD, and an anti-CD38 mAb. * Must be eligible to receive the Investigator's choice standard available therapy (SAT) based on approved prescribing information, previous MM treatment history, and institutional guidelines. Exclusion Criteria: * Clinically significant (per Investigator's judgment) drug or alcohol abuse within the last 6 months. * Clinically significant conditions such as but not limited to the following: neurologic, psychiatric, endocrine, metabolic, immunologic, cardiovascular, pulmonary, or hepatic disease within the last 6 months that would adversely affect the participant's participation in the study. * Central nervous system involvement of MM. * Has received B-cell maturation antigen (BCMA)-targeted therapy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple myeloma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 256808
Turin, Piedmont, 10126, Italy
-
AOU Policlinico G. Rodolico - San Marco /ID# 256814
Catania, 95123, Italy
-
ASST Ovest Milanese /ID# 256813
Legnano, Milano, 20025, Italy
-
Addenbrookes Hospital /ID# 261104
Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom
-
Alberts Cellular Therapy /ID# 245725
Pretoria, Gauteng, 0044, South Africa
-
Alexandra General Hospital /ID# 240591
Athens, Attica, 11528, Greece
-
Algemeen Ziekenhuis Sint-Jan Brugge /ID# 245345
Bruges, West-Vlaanderen, 8000, Belgium
-
Algemeen Ziekenhuis klina /ID# 260856
Brasschaat, Antwerpen, 2930, Belgium
-
Alta Bates Summit Medical Center for Research /ID# 261438
Berkeley, California, 94705, United States
-
Anjo Kosei Hospital /ID# 263434
Anjo, Aichi-ken, 446-8602, Japan
-
Antalya Egitim Ve Arastirma Hastanesi /ID# 261674
Antalya, 07100, Turkey (Türkiye)
-
Atrium Health Levine Cancer Institute /ID# 246199
Charlotte, North Carolina, 28204, United States
-
Auxilio Mutuo Cancer Center /ID# 272565
San Juan, 00918, Puerto Rico
-
Azienda Ospedaliero Universitaria delle Marche /ID# 256812
Ancona, 60126, Italy
-
Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 256810
Rome, Roma, 00161, Italy
-
Baptist Memorial Hospital /ID# 270910
Memphis, Tennessee, 38120, United States
-
Barbara Ann Karmanos Cancer Institute - McLaren Greater Lansing /ID# 259891
Lansing, Michigan, 48912, United States
-
Beijing Chaoyang Hospital,Capital Medical University /ID# 245533
Beijing, Beijing Municipality, 100020, China
-
Beth Israel Deaconess Medical Center /ID# 271535
Boston, Massachusetts, 02215, United States
-
Box Hill Hospital /ID# 262784
Melbourne, Victoria, 3128, Australia
-
CH Henri Duffaut /ID# 261844
Avignon, Vaucluse, 84902, France
-
CH Saint-Quentin /ID# 261856
Saint-Quentin, Aisne, 02321, France
-
Calvary Mater Newcastle /ID# 261804
Waratah, New South Wales, 2298, Australia
-
Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 246230
Jacksonville, Florida, 32256, United States
-
Cedars-Sinai Medical Center /ID# 261008
Los Angeles, California, 90048, United States
-
Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 263637
Bethesda, Maryland, 20817, United States
-
Centre Hospitalier Regional d Orleans - Hopital de la Source /ID# 261854
Orléans, Loiret, 45067, France
-
Centre Hospitalier du Mans /ID# 261852
Le Mans, Sarthe, 72037, France
-
Centrum fuer Haematologie und Onkologie Bethanien /ID# 271982
Frankfurt am Main, 60389, Germany
-
Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 260689
Berlin, 12203, Germany
-
Chiba University Hospital /ID# 262006
Chiba, Chiba, 260-8677, Japan
-
China Medical University Hospital /ID# 245483
Taichung, 40447, Taiwan
-
Chugoku Central Hospital /ID# 263431
Fukuyama, Hiroshima, 720-0001, Japan
-
Cleveland Clinic Main Campus /ID# 246183
Cleveland, Ohio, 44195, United States
-
Complejo Hospitalario Universitario Ourense /ID# 246400
Ourense, Ourense, 32005, Spain
-
Constantiaberg Haematology /ID# 261320
Cape Town, Western Cape, 7800, South Africa
-
Dana-Farber Cancer Institute /ID# 261554
Boston, Massachusetts, 02215, United States
-
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 261672
Ankara, 06200, Turkey (Türkiye)
-
Duke University Medical Center /ID# 259694
Durham, North Carolina, 27710, United States
-
Dup_Guys and St Thomas NHS Foundation Trust - Guy's Hospital /ID# 262488
London, Greater London, SE1 9RT, United Kingdom
-
Eastchester Center for Cancer Care /ID# 262952
The Bronx, New York, 10469, United States
-
Fakultni Nemocnice Brno - Jihlavska /ID# 245689
Brno, Brno-mesto, 625 00, Czechia
-
Fakultni Nemocnice Ostrava /ID# 245686
Ostrava, Ostrava-mesto, 708 52, Czechia
-
Fakultni nemocnice Hradec Kralove - Sokolska /ID# 245690
Hradec Králové, 500 05, Czechia
-
Falu Lasarett /ID# 262231
Falun, 791 82, Sweden
-
First Affiliated Hospital of China Medical University /ID# 245547
Shenyang, Liaoning, 110001, China
-
Fujian Medical University Union Hospital /ID# 245558
Fuzhou, Fujian, 350001, China
-
Fundacao Champalimaud /ID# 246258
Lisbon, Lisbon District, 1400-038, Portugal
-
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 240596
Athens, 10676, Greece
-
General University Hospital of Thessaloniki AXEPA /ID# 240595
Thessaloniki, 54636, Greece
-
Gifu Municipal Hospital /ID# 263321
Gifu, Gifu, 500-8323, Japan
-
Gunma University Hospital /ID# 262580
Maebashi, Gunma, 371-8511, Japan
-
Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 261648
Győr, Győr-Moson-Sopron, 9024, Hungary
-
Haemalife Inc. /ID# 245724
Kuils River, Western Cape, 7580, South Africa
-
Helsingborgs Lasarett /ID# 262513
Helsingborg, Skåne County, 251 87, Sweden
-
Hematology And Oncology Institute /ID# 272531
Manati, 00674, Puerto Rico
-
Henan Cancer Hospital /ID# 245536
Zhengzhou, Henan, 450008, China
-
Henry Ford Hospital /ID# 262704
Detroit, Michigan, 48202, United States
-
Hospital General Universitario Gregorio Maranon /ID# 246401
Madrid, 28007, Spain
-
Hospital Universitario de Salamanca /ID# 262218
Salamanca, 37711, Spain
-
Hospital Universitario y Politecnico La Fe /ID# 261625
Valencia, 46026, Spain
-
Hospital de Leon /ID# 261624
León, 24071, Spain
-
Hyogo Prefectural Amagasaki General Medical Center /ID# 265696
Amagasaki, Hyōgo, 660-8550, Japan
-
Institute of Hematology and Blood Diseases Hospital /ID# 265702
Tianjin, Tianjin Municipality, 300020, China
-
Instituto Catalan de Oncologia (ICO) Badalona /ID# 246398
Badalona, Barcelona, 08916, Spain
-
Instituto Portugues de Oncologia do Porto Francisco Gentil /ID# 246257
Porto, 4200-072, Portugal
-
Istanbul Florence Nightingale Hospital /ID# 271543
Şişli, Istanbul, 34381, Turkey (Türkiye)
-
Japanese Red Cross Medical Center /ID# 261717
Shibuya-ku, Tokyo, 150-8935, Japan
-
Karmanos Cancer Institute - Detroit /ID# 266298
Detroit, Michigan, 48201, United States
-
Klinik Ottakring /ID# 245829
Vienna, State of Vienna, 1160, Austria
-
Klinikum Chemnitz - Flemmingstrabe /ID# 273108
Chemnitz, Saxony, 09116, Germany
-
Kyushu University Hospital /ID# 264704
Fukuoka, Fukuoka, 812-8582, Japan
-
Leeds Teaching Hospitals NHS Trust /ID# 261101
Leeds, West Yorkshire, LS9 7TF, United Kingdom
-
Liverpool Hospital /ID# 262159
Liverpool, New South Wales, 2170, Australia
-
Mayo Clinic - Rochester /ID# 246228
Rochester, Minnesota, 55905-0001, United States
-
Mayo Clinic Hospital - Phoenix /ID# 263326
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Hospital Jacksonville /ID# 263324
Jacksonville, Florida, 32224, United States
-
Medical University of South Carolina /ID# 259692
Charleston, South Carolina, 29425, United States
-
Medizinische Universitaet Graz /ID# 261908
Graz, Styria, 8010, Austria
-
Miyagi Cancer Center /ID# 265094
Natori-shi, Miyagi, 981-1293, Japan
-
Monash Health - Monash Medical Centre - Clayton /ID# 262158
Clayton, Victoria, 3168, Australia
-
Nagoya City University Hospital /ID# 263320
Nagoya, Aichi-ken, 467-8602, Japan
-
Naha City Hospital /ID# 263972
Naha, Okinawa, 902-0061, Japan
-
Nancy W. Knowles Cancer Center /ID# 271361
Elmhurst, Illinois, 60126, United States
-
National Taiwan University Hospital /ID# 245482
Taipei, 100, Taiwan
-
Nebraska Cancer Specialists - Omaha - Wright Street /ID# 276772
Omaha, Nebraska, 68130, United States
-
New York Cancer & Blood Specialists - Bay Shore /ID# 261524
Bay Shore, New York, 11706, United States
-
New York Cancer & Blood Specialists - Lake Success Medical Oncology /ID# 262953
New Hyde Park, New York, 11042, United States
-
New York Cancer and Blood Specialists - New York /ID# 262951
New York, New York, 10028, United States
-
Northwest Medical Specialties Tacoma /ID# 276281
Tacoma, Washington, 98405, United States
-
Nottingham City Hospital /ID# 261105
Nottingham, Nottinghamshire, NG5 1PB, United Kingdom
-
Odense University Hospital /ID# 260924
Odense, Region Syddanmark, 5000, Denmark
-
Oncology Consultants /ID# 276774
Houston, Texas, 77030, United States
-
Ordensklinikum Linz Elisabethinen /ID# 245609
Linz, Upper Austria, 4010, Austria
-
Oregon Medical Research Center /ID# 262335
Portland, Oregon, 97239, United States
-
Our Lady Of The Lake Regional Medical Center /ID# 272780
Baton Rouge, Louisiana, 70808, United States
-
Peking Union Medical College Hospital East - Dongdan Campus /ID# 245545
Beijing, Beijing Municipality, 100730, China
-
People's Hospital of Henan Province /ID# 260918
Zhengzhou, Henan, 450003, China
-
Princess Alexandra Hospital - Woolloongabba /ID# 261810
Woolloongabba, Queensland, 4102, Australia
-
Providence - St. Jude Medical Center /ID# 262031
Fullerton, California, 92835, United States
-
Rabin Medical Center. /ID# 245498
Petah Tikva, Central District, 4941492, Israel
-
Regents of the University of Michigan /ID# 261577
Ann Arbor, Michigan, 48109-1276, United States
-
Rocky Mountain Cancer Centers - Lone Tree /ID# 278320
Lone Tree, Colorado, 80124, United States
-
Rush University Medical Center /ID# 265690
Chicago, Illinois, 60612, United States
-
Saitama Prefectural Cancer Center /ID# 262586
Kitaadachi-gun, Saitama, 362-0806, Japan
-
Samsung Medical Center /ID# 245492
Seoul, Seoul Teugbyeolsi, 06351, South Korea
-
Second Affiliated Hospital of Xian Jiaotong University /ID# 261255
Xi'an, Shaanxi, 710004, China
-
Semmelweis Egyetem /ID# 261646
Budapest, 1085, Hungary
-
Semmelweis Egyetem /ID# 261647
Budapest, 1085, Hungary
-
Seoul National University Hospital /ID# 245491
Seoul, Seoul Teugbyeolsi, 03080, South Korea
-
Shaare Zedek Medical Center /ID# 245681
Jerusalem, Jerusalem, 91031, Israel
-
Shanghai Tongji Hospital /ID# 245539
Shanghai, Shanghai Municipality, 200065, China
-
Sir Run Run Shaw Hospital Zhejiang University School of Medicine /ID# 260882
Hangzhou, Zhejiang, 310020, China
-
Springfield Clinic - First /ID# 262266
Springfield, Illinois, 62702, United States
-
St George Hospital - Kogarah /ID# 261806
Kogarah, New South Wales, 2217, Australia
-
St Vincent's Hospital Melbourne /ID# 261808
Fitzroy Melbourne, Victoria, 3065, Australia
-
Staedtisches Klinikum Karlsruhe /ID# 272377
Karlsruhe, Baden-Wurttemberg, 76133, Germany
-
Sun Yat-Sen University Cancer Center /ID# 245542
Guangzhou, Guangdong, 510060, China
-
Taichung Veterans General Hospital /ID# 261142
Taichung, 40705, Taiwan
-
Tel Aviv Sourasky Medical Center /ID# 245495
Tel Aviv, Tel Aviv, 6423906, Israel
-
Texas Oncology - Northeast Texas /ID# 278304
Tyler, Texas, 75702, United States
-
The Catholic University of Korea, Seoul St. Marys Hospital /ID# 245493
Seoul, Seoul Teugbyeolsi, 06591, South Korea
-
The Chaim Sheba Medical Center /ID# 245497
Ramat Gan, Tel Aviv, 5265601, Israel
-
The Christie Hospital /ID# 261102
Manchester, M20 4BX, United Kingdom
-
The First Affiliated Hospital of Nanchang University /ID# 245537
Nanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Soochow University /ID# 245544
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of Wenzhou Medical University /ID# 245550
Wenzhou, Zhejiang, 325000, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 260883
Hangzhou, Zhejiang, 310003, China
-
The Royal Marsden NHS Foundation Trust /ID# 262470
London, SW3 6JJ, United Kingdom
-
The University of Osaka Hospital /ID# 263974
Suita-shi, Osaka, 565-0871, Japan
-
The West Clinic /ID# 262444
Memphis, Tennessee, 38120, United States
-
Tianjin Medical University General Hospital /ID# 260851
Tianjin, Tianjin Municipality, 300052, China
-
Tokyo Metropolitan Komagome Hospital /ID# 277567
Bunkyo Ku, Tokyo, 113-8677, Japan
-
Trakya University Medical Facu /ID# 261673
Edirne, Istanbul, 22030, Turkey (Türkiye)
-
Uddevalla sjukhus /ID# 262034
Uddevalla, Västra Götaland County, 451 80, Sweden
-
Ulsan University Hospital /ID# 245490
Ulsan, Ulsan Gwang Yeogsi, 44033, South Korea
-
Unidade Local de Saude de Santa Maria /ID# 246255
Lisbon, 1649-035, Portugal
-
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 245549
Wuhan, Hubei, 430022, China
-
Universitaetsklinikum Freiburg /ID# 262147
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
Universitaetsklinikum Hamburg-Eppendorf /ID# 260651
Hamburg, 20246, Germany
-
Universitaetsklinikum Krems /ID# 261509
Krems, Lower Austria, 3500, Austria
-
University General Hospital Attikon /ID# 240592
Chaïdári, Attica, 12462, Greece
-
University Health Network_Princess Margaret Cancer Centre /ID# 261566
Toronto, Ontario, M5G 2M9, Canada
-
University Hospital Kyoto Prefectural University of Medicine /ID# 262585
Kyoto, Kyoto, 602-8566, Japan
-
University Of Cincinnati Medical Center /ID# 246415
Cincinnati, Ohio, 45219, United States
-
University of Alabama at Birmingham - Main /ID# 261434
Birmingham, Alabama, 35233, United States
-
University of Fukui Hospital /ID# 264222
Yoshida-gun, Fukui, 910-1104, Japan
-
University of Illinois Hospital and Health Sciences System /ID# 246349
Chicago, Illinois, 60607, United States
-
University of Missouri Hospital /ID# 261553
Columbia, Missouri, 65212, United States
-
University of North Carolina /ID# 259854
Chapel Hill, North Carolina, 27514, United States
-
University of Tennessee Health Science Center /ID# 261622
Memphis, Tennessee, 38103, United States
-
University of Yamanashi Hospital /ID# 262912
Chuo-shi, Yamanashi, 409-3898, Japan
-
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie /ID# 260168
Lublin, Lublin Voivodeship, 20-081, Poland
-
Uniwersytecki Szpital Kliniczny We Wroclawiu /ID# 260172
Wroclaw, Lower Silesian Voivodeship, 50-556, Poland
-
Uniwersyteckie Centrum Kliniczne /ID# 260169
Gdansk, Pomeranian Voivodeship, 80-214, Poland
-
VA Loma Linda Healthcare System /ID# 261015
Loma Linda, California, 92357, United States
-
VCU Massey Cancer Center: Dalton Oncology Clinic /ID# 261944
Richmond, Virginia, 23298, United States
-
Vanderbilt University Medical Center /ID# 261621
Nashville, Tennessee, 37232-0011, United States
-
Vejle Sygehus /ID# 260923
Vejle, Region Syddanmark, 7100, Denmark
-
Virginia Cancer Specialists - Fairfax /ID# 262792
Fairfax, Virginia, 22031, United States
-
Virginia Oncology Associates - Norfolk (Lake Wright) /ID# 278314
Norfolk, Virginia, 23502, United States
-
Vseobecna Fakultni nemocnice v Praze /ID# 245691
Prague, Praha 17, 128 00, Czechia
-
Western General Hospital /ID# 261106
Edinburgh, Edinburgh, City of, EH4 2XU, United Kingdom
-
Winship Cancer Institute of Emory University /ID# 262525
Atlanta, Georgia, 30322, United States
-
Yonsei University Health System Severance Hospital /ID# 245489
Seoul, 03722, South Korea
-
Zhongda Hospital Southeast University /ID# 245563
Nanjing, Jiangsu, 210009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Bispecific antibody combo aims to deepen myeloma responses
- Can a stronger drug cocktail give older myeloma patients a better start?
- Cheap blood count ratios eyed as window into Myeloma's inflammatory grip
- Can a t-cell engager rescue myeloma that outsmarted CAR-T?
- Can myeloma treatment work without steroids?
- Double-Drug attack on Hard-to-Treat lymphomas